Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.65 |
| ▸ | LIPC | P11150 | 1/20 | 0.65 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.51 |
| ▸ | NAAA | Q02083 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7043047 | 1.00 | LIPG (0.65) | LIPGLIPCALOX5NAAATSHR | |
| SCHEMBL8912311 | 0.98 | LIPG (0.67) | LIPGLIPCALOX5NAAATSHR | |
| SCHEMBL6858842 | 0.95 | LIPG (0.67) | LIPGLIPCALOX5NAAATSHR | |
| SCHEMBL8333948 | 0.94 | LIPG (0.60) | LIPGLIPCALOX5NAAATSHR | |
| SCHEMBL8336135 | 0.93 | LIPG (0.61) | LIPGLIPCALOX5NAAATSHR | |
| SCHEMBL8334416 | 0.91 | LIPG (0.62) | LIPGLIPCALOX5NAAATSHR | |
| SCHEMBL6862929 | 0.88 | LIPG (0.58) | LIPGLIPCALOX5NAAATSHR | |
| SCHEMBL19577104 | 0.88 | LIPG (0.58) | LIPGLIPCALOX5TSHRHTT | |
| SCHEMBL29785646 | 0.88 | LIPG (0.58) | LIPGLIPCALOX5NAAATSHR | |
| SCHEMBL8892358 | 0.88 | LIPG (0.58) | LIPGLIPCALOX5TSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190287691-A1 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-09-19 | — | — | US | disclosed |
| EP-0840727-B1 | 3-HYDROXY-2(1H)-PYRIDINONE CHELATING AGENTS | UNIV CALIFORNIA (US) | 2004-05-06 | — | — | EP | disclosed |
| US-5624901-A | CARBAMOYL SUBSTITUTED COMPOUNDS FOR CHELATE COMPOUNDS FOR MAGNETIC RESONANCE IMAGING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190287691-A1 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | SLC39A14, SLC39A11, SLC39A7 | LIPG 832/4885LIPC 1916/4885ALOX5 4199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.